￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Medical News

Capmatinib’s launch time and indications

2025-10-19 11:44:20

Check Details
Overview of the purchase price and field application of capmatinib

2025-10-19 11:44:20

Check Details
New drug for targeted treatment of gastrointestinal stromal tumors: Ripotinib

2025-10-19 11:44:20

Check Details
Guide to dietary taboos while taking crizotinib

2025-10-19 11:44:20

Check Details
The fourth domestic MET inhibitor: tepotinib hydrochloride was approved for marketing

2025-10-19 11:44:20

Check Details
Entrectinib purchase and analysis of its effects

2025-10-19 11:44:20

Check Details
Detailed explanation of the efficacy and side effects management of ceritinib

2025-10-19 11:44:20

Check Details
The efficacy and safety of Yiluake Tablets (Qixinke) in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Application of Yiluake Tablets (Qixinke) in the treatment of ALK-positive lung cancer

2025-10-19 11:44:20

Check Details
A brief introduction to the precautions and contraindications of the anaplastic lymphoma kinase (ALK)-positive lung cancer drug alectinib

2025-10-19 11:44:20

Check Details
The efficacy of dabrafenib in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The mechanism and precautions of Ripotinib

2025-10-19 11:44:20

Check Details
Category
相关知识